Tata Elxsi wins prestigious iF Design Award for two of its user centric solutions
Tata Elxsi has been awarded the prestigious iF Design Award for two of its standout innovations: VelocityOne Race, designed for Nasdaq-listed Turtle Beach Corporation, a leading American gaming accessory manufacturer, and GameSense, developed for leading broadcasters and operators.
VelocityOne Race was recognised in the Product - Gaming Hardware/VR/AR category, while GameSense won in the User Experience (UX) category. This dual recognition reinforces Tata Elxsi's leadership in delivering design-led, immersive solutions for the gaming and sports technology industries.
Now in its 72nd year, the iF Design Award is among the world's most respected accolades for excellence in design. The 2025 edition saw more than 11,000 entries from 72 countries, evaluated by a global panel of 131 independent experts based on criteria such as Idea, Form, Function, Differentiation, and Sustainability.
VelocityOne Race, developed for Turtle Beach Corporation, is a high-performance racing simulation system designed for maximum immersion. It delivers the most realistic sim racing experience in the worldpowered by cutting-edge technology and human-centered design.
Tata Elxsi led the industrial design, user interface development, and engineering integration of the system. This included the Race Management Display (RMD) and the VelocityOne Tuner app, both developed to enhance real-time telemetry access and gameplay customisation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
37 minutes ago
- Time of India
Centre keeps tabs on Trump tariff concessions to other nations
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel As the American delegation arrives in the capital to negotiate the proposed bilateral trade agreement, the government is closely monitoring the ongoing legal issues surrounding Trump 's tariffs and the concessions the US is granting to other nations, since the discussions are centered on improving market access for both countries, as per a TOI Trump administration is seeking to use the 10% baseline tariffs and the suspended reciprocal tariffs (26% in India's case) to negotiate trade deals. The court setback, which was stayed a day later, has injected fresh uncertainty, and govt is keen to ensure that it manages to extract the best deal for Indian companies. "What we get compared to other we will ultimately finalise in the deal," a govt official the same time India is conscious of the strategic ties with the US and is looking to step up import of shale gas, LNG, and crude oil from America to diversify its import basket, as prices of these items are lower in the US, an official said. This is expected to help bridge the trade gap of over $40 billion in India's favour, a major grudge with Trump, who has been doling out various numbers to justify his tariffs the US administration works out the trade deal will also determine govt's future course of action on retaliating against some of the tariff hikes introduced by Trump, such as those on steel and aluminium products."Exports are increasing... there are several things we can buy from the US... For example shale gas, LNG, crude oil. The more diversified our sources, the greater the benefit for us. Prices are also low in the US," the official, who did not wish to be named, said.(With TOI inputs)
Time of India
an hour ago
- Time of India
'You can't fight a war without American steel': US declares economic war on Canada, the ally that armed it in WWII with steel
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel The United States has doubled its protectionist stance by increasing tariffs on imported steel and aluminum to 50%, which has alarmed Canadian producers and raised concerns across North American supply chains. The decision, signed by US President Donald Trump and effective June 5, is already being felt sharply in Canada , the largest steel exporter to the Commerce Secretary Howard Lutnick defended the tariff hike during testimony before the Senate Appropriations Committee on Wednesday, June gave national security as the primary rationale behind the decision and said, 'You can't fight a war without steel and aluminum production in America,'. 'If you don't have the ability to make your own steel and aluminum, you can't fight a war, and that is what the president's doing. He's trying to make sure that we make sufficient steel and aluminum to protect our defence.'However, the move has triggered backlash, particularly from Democratic Senator Jeanne Shaheen of New Hampshire, who questioned whether the Pentagon had been consulted and raised concerns about long lead times and reduced access to key cited a ball bearing manufacturer in her state that relies heavily on Canadian and Indo-Pacific steel suppliers, noting that lead times for materials had jumped from 20 weeks to more than two downplayed the access issue, calling it a 'cost issue,' not a supply crisis. When Shaheen pushed back, highlighting the real-world production delays faced by US companies, Lutnick insisted that tariffs were monetary and not equivalent to steel and aluminum producers, however, are warning of significant damage. Catherine Cobden, President and CEO of the Canadian Steel Producers Association, said the tariff hike is 'creating chaos and disruption throughout North American supply chains and delivering a crushing blow to the Canadian steel industry.'Cobden noted that even at the previous 25% tariff rate, Canada experienced layoffs, lost investments, and a drop in US shipments. 'At a 50 per cent tariff rate, the US market is effectively closed to Canadian steel, and will leave billions of dollars of Canadian steel without a market,' she and his administration have justified the tariff hike by arguing that relying on foreign steel, especially from China, poses a national security risk. White House economic advisor Kevin Hassett warned that countries like China are 'dumping' steel to dominate global production and prepare for potential military has long been a critical supplier of steel and aluminum to the US, particularly for the defense and aerospace sectors. Canadian materials have supported American military manufacturing from World War II through modern conflicts. To counter the latest tariffs, the Carney administration has pledged to increase domestic defense production using Canadian steel and aluminum to reduce reliance on the US and support local these dynamic trade tensions, the ripple effects of Trump's tariff policy are felt in Canadian and US industries, which depend on steady, affordable access to raw materials. The debate over economic security versus national defense is far from over.
The Hindu
an hour ago
- The Hindu
Dr. Reddy's, Alvotech to co-develop, market biosimilar of Merck's cancer drug Keytruda
Pharma major Dr. Reddy's Laboratories and Nasdaq-listed global biotech firm Alvotech will co-develop, manufacture and commercialise a biosimilar candidate to Merck's cancer drug Keytruda (pembrolizumab) for global markets. They will be jointly responsible for developing and manufacturing the biosimilar candidate and sharing costs as well as the responsibilities. 'Subject to certain exceptions, each party will have the right to commercialise the product globally,' Dr. Reddy's and Alvotech said on Thursday (June 5, 2025) in a joint statement announcing the signing of a licence agreement. The collaboration will combine their proven capabilities in biosimilars thus speeding up the development process and extending global reach for the biosimilar candidate. A registered trademark of Merck Sharp & Dohme Corp, Keytruda is indicated for the treatment of numerous cancer types. In 2024, the worldwide sales of Keytruda were $29.5 billion. Oncology top focus therapy 'Oncology has been a top focus therapy area for us and this collaboration will further enhance our capabilities in oncology, as pembrolizumab currently represents one of the most critical therapies in immuno-oncology,' Dr. Reddy's CEO Erez Israeli said. Alvotech chairman and CEO Robert Wessman said 'we are pleased to enter into this collaboration for pembrolizumab with Dr. Reddy's. This agreement demonstrates Alvotech's ability to leverage its dedicated R&D and manufacturing platform for biosimilars, accelerating the expansion of our pipeline by pursuing growing global markets.'
